2013
DOI: 10.1158/2159-8290.cd-12-0305
|View full text |Cite
|
Sign up to set email alerts
|

Unbiased Metabolite Profiling Indicates That a Diminished Thymidine Pool Is the Underlying Mechanism of Colon Cancer Chemoprevention by Alpha-Difluoromethylornithine

Abstract: The ornithine decarboxylase (ODC) inhibitor, α-difluoromethylornithine (DFMO), is a highly effective chemopreventative agent for colorectal cancer (CRC) thought to act via polyamine depletion. However, in DFMO treated patients, mucosal polyamine levels do not directly correlate with CRC risk. Untargeted metabolite profiling was used to broadly survey DFMO actions on colon cancer cell metabolism. Some studies revealed that DFMO treatment of ApcMin intestinal tumors and human CRC cells is associated with reduced… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
46
3

Year Published

2014
2014
2021
2021

Publication Types

Select...
7
2

Relationship

1
8

Authors

Journals

citations
Cited by 43 publications
(51 citation statements)
references
References 40 publications
2
46
3
Order By: Relevance
“…Thymidine depletion is the basis for anti-proliferative therapies that range from antibiotics (Hawser et al, 2006; Kwon et al, 2010) to cancer chemotherapy (Gangjee et al, 2007; Witherspoon et al, 2013). The success of drugs that target thymidine pools highlights the importance of generating this nucleotide in proliferating cells.…”
Section: Discussionmentioning
confidence: 99%
“…Thymidine depletion is the basis for anti-proliferative therapies that range from antibiotics (Hawser et al, 2006; Kwon et al, 2010) to cancer chemotherapy (Gangjee et al, 2007; Witherspoon et al, 2013). The success of drugs that target thymidine pools highlights the importance of generating this nucleotide in proliferating cells.…”
Section: Discussionmentioning
confidence: 99%
“…A metabolomic approach applied to colorectal cancer models led to the hypothesis that reduced cellular thymidine pools contribute to DFMO-induced cytostatic activity (52). DFMO-mediated polyamine depletion leads to compensatory hyperactivation of Amd1 with futile S-adenosylmethionine consumption, followed by depletion of folate-dependent metabolites and thymidine.…”
Section: Discussionmentioning
confidence: 99%
“…Metabolomics has shed light on the changes in metabolism that accompany diseases and drug treatment [2], identified changes in metabolism of human diseases such as cancer [3, 4], and provide vital biological insights through the study of a wide variety of organisms [5, 6]. …”
Section: Introductionmentioning
confidence: 99%